SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043229
Filing Date
2019-11-13
Accepted
2019-11-13 16:11:27
Documents
56
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acer-10q_20190930.htm 10-Q 1558391
2 EX-10.1 acer-ex101_193.htm EX-10.1 109070
3 EX-10.2 acer-ex102_194.htm EX-10.2 109086
4 EX-31.1 acer-ex311_7.htm EX-31.1 17839
5 EX-31.2 acer-ex312_9.htm EX-31.2 17512
6 EX-32.1 acer-ex321_8.htm EX-32.1 7899
7 EX-32.2 acer-ex322_6.htm EX-32.2 7698
8 GRAPHIC gwv0f5flgnhz000001.jpg GRAPHIC 1836
  Complete submission text file 0001564590-19-043229.txt   4813375

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT acer-20190930.xml EX-101.INS 741302
10 XBRL TAXONOMY EXTENSION SCHEMA acer-20190930.xsd EX-101.SCH 36711
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acer-20190930_cal.xml EX-101.CAL 36076
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acer-20190930_def.xml EX-101.DEF 104811
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE acer-20190930_lab.xml EX-101.LAB 332394
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acer-20190930_pre.xml EX-101.PRE 228345
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33004 | Film No.: 191214099
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences